Thus, considering the complexity of EBV infection, broadening antigen spectrum is important for generation of potent neutralizing antibodies targeting different EBV envelop glycoproteins, which may completely block EBV infection in vivo. Here, ERVW-1 is linked to Epstein-Barr virus infection.